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Previewsesterification and LD formation could also
be relevant in other tumor types. For
instance, clear cell renal cell carcinomas
(ccRRCs) are characterized by the pres-
ence of glycogen stores and abundant
LDs (Straub et al., 2010). Indeed, ccRCCs
display vastly elevated levels of free
cholesterol and cholesteryl esters
compared to normal kidney tissue (Geb-
hard et al., 1987). Targeting cholesterol
esterification could thus also have benefits
in other cancer types. Interestingly, ACAT
inhibitors have already undergone toxico-
logical analysis and are used in humans.
Avasimibe, the agent used to inhibit
ACAT in this study, is currently
undergoing clinical trials for the treatment
of hyperlipidemia and atherosclerosis.
Like statins or metformin, this may provide
another example of a drug originally devel-
oped to targetmetabolic diseases that can
be repurposed for the treatment, and
possibly prevention, of cancer. Old drugs
could indeed perform new tricks when
used in the appropriate setting (Gronich
and Rennert, 2013).
However, there are also cautionary
notes raised by the work presented in
this paper. Interestingly, supplementation352 Cell Metabolism 19, March 4, 2014 ª201of culture medium with exogenous low-
density lipoprotein (LDL) or arachidonic
acid rescued the toxicity of ACAT inhibi-
tors (Figure 1). Although the authors did
not investigate the effect of exogenous
lipids in vivo, this result suggests that die-
tary regimens that produce elevated
levels of circulating LDL or AA could
restrict ACAT inhibitor efficacy (Yue
et al., 2014). This observation comple-
ments previous results demonstrating
that the lipolytic enzyme monoacylgly-
cerol lipase (MAGL) is important in
aggressive cancers and that its ablation
resulted in reduced tumor growth. How-
ever, this effect was completely lost
when mice were fed a high-fat diet (No-
mura et al., 2010). The impact of diet on
the metabolism of cancer cells is an
urgent issue. Dietary regimens should be
considered during preclinical research
and then be translated into the clinic if
potential targets in cancer metabolism
are to fulfill their promise.REFERENCES
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The thermogenic capacity of brown adipose tissue (BAT) in response to cold is relatively well established in
humans. Several hormones and factors are involved in this response, and Lee et al. (2014) now provide
evidence for a role of irisin and FGF21 in BAT thermogenic activity in humans.In response to low-temperature exposure
or prolonged stay in a mild cold environ-
ment, warm-blooded animals may initiate
shivering, a muscular response aimed at
maintaining the proper body temperature.
However, before the surrounding temper-
ature decreases enough to activate shiv-
ering, a nonshivering phase occurs, in
which brown adipose tissue (BAT) is acti-vated for heat production. This response
involves rapid (within minutes) activation
of signal transduction via neuronal path-
ways and heat release via UCP-1 induc-
tion in BAT sites such as the supraclavic-
ular region (Symonds et al., 2012). Among
the known factors and hormones involved
in this response is norepinephrine (NE),
which mediates the activation of thesympathetic nervous system. NE induces
fibroblast growth factor 21 (FGF21)
gene transcription and release in BAT
(Hondares et al., 2011), which, in turn
promotes lipolysis by the activation of
hormone sensitive lipase (HSL). Conse-
quently, the intracellular lipids released
by lipolysis within brown adipocytes are
directed to active mitochondria for heat
Figure 1. The Effects of Cold (Nonshivering and Shivering) and Exercise on FGF21 and Irisin
Cold induces both nonshivering and shivering thermogenesis. Shivering and exercise involve skeletal
muscle, while nonshivering effects are directed to brown adipose tissue (BAT). Both cold and exercise
activate the sympathetic nervous system, and the resulting noradrenergic stimulus induces lipolysis
both in BAT and in white adipose tissue (WAT). Fibroblast growth factor 21 (FGF21), which is activated
by norepinephrine, induces hormone-sensitive lipase (HSL) and other genes associated with oxidative
and thermogenic activity, thus leading to increased thermogenesis in BAT. FGF21 also induces browning
in subcutaneousWAT in cooperation with irisin, which is secreted by themuscles as a result of shivering or
exercise. Excess fatty acids from the enhanced lipolysis are oxidized and consumed in BAT and subcu-
taneous WAT (scWAT).
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Previewsproduction. Interestingly, exercise also
promotes adipose tissue- mediated ther-
mogenesis via secretion of the myokine
irisin. Lee et al. (2014) now show that
shivering is also associated with irisin
secretion, thus linking exercise- and
cold-induced thermogenesis.
Myokines are released from muscles in
response to exercise. They signal to other
organs an increased need for fuel, acti-
vating glycogenolysis in muscle, and
gradually increasing lipolysis in adipose
tissue (Stich et al., 2000). Indeed, repeated
exercise bouts (cycling or swimming) in
mice result in an increased adipocyte
UCP1 expression, specifically in inguinal
subcutaneous adipose tissue (Bostro¨m
et al., 2012). Irisin was one of the first
myokines found to activate such adipose
tissue browning in rodents in response to
exercise (Bostro¨m et al., 2012). These
effects aremediated by the transcriptional
coactivator PGC1-a, which is activated by
exercise and in turn induces expression of
the FNDC5 gene and membrane protein;
FNDC5 is then cleaved to release irisin
(Bostro¨m et al., 2012).
In a recent paper, Lee et al. (2014)
describe the effects of cold, shivering,
and exercise on FGF21 and irisin. Theyshow that exposure to cold increases
plasma FGF21 and serum irisin in healthy
human volunteers and that induction of
irisin is associated with more intense shiv-
ering, as determined using electromyog-
raphy (EMG), a technique for measuring
muscle electrical activity. The concentra-
tion of irisin in serum increases on average
from 10 to 20 ng/ml during cold exposure.
It remains unchanged after a maximal ex-
ercise test, in which volunteers exercise
to exhaustion, but increases from an
average of 10 up to 30 ng/ml after a sub-
maximal exercise test, in which volun-
teers exercise at a lower intensity for the
same or longer periods of time (Lee
et al., 2014). Thus, shivering induces irisin
secretion at levels almost comparable to
those induced by exercise, suggesting
that shivering links exercise- and cold-
induced thermogenesis.
Lee et al. then tested the effects of the
two cytokines on adipocytes. They used
irisin and FGF21 to treat in vitro human
neck adipocytes, which have BAT-like
characteristics, and primary human sub-
cutaneous and omental adipocytes, typi-
cally without BAT characteristics. Both
irisin and FGF21, and especially their
combination, resulted in significant heatCell Metabolismproduction in neck and subcutaneous ad-
ipocytes—although to a lesser extent
in the subcutaneous adipocytes—but
omental adipocytes did not respond to
the treatment. These results may reflect
the browning capacity of certain adipo-
cytes, namely those that are anatomically
situated where they can be exposed to
environmental cold. These adipocytes
may be activated by cytokines to produce
heat, in order to maintain proper body
temperature, but they may also be har-
nessed to burn excess fatty acids pro-
duced by systemic lipolysis in white
adipose tissue (WAT) in response to
both cold and exercise. Both cold and ex-
ercise activate the sympathetic nervous
system, through which NE stimulates
HSL in WAT, resulting in breakdown of
triglyceride stores (Figure 1).
The above results suggest that FGF21
and irisin function in concert during cold
and shivering. In addition, FGF21 has a
dual role inducing beneficial changes in
adipose tissue. Cold temperature induces
FGF21 expression and release from BAT
both in rodents (Hondares et al., 2011)
and in humans (Lee et al., 2013, Lee
et al., 2014). The released FGF21 has
endocrine effects on WAT (i.e., browning)
but may also have autocrine effects
(Potthoff et al., 2012). Interestingly,
FGF21 release may in turn depend on
the presence of BAT. Under normal
temperature conditions, FGF21 shows a
diurnal rhythm with plasma concentra-
tions ranging on average between 50
and 100 pg/ml, being highest in the morn-
ing (Lee et al., 2013). This rhythm is blunt-
ed by cold exposure. Now Lee et al. show
that FGF21 diurnal variation is more effec-
tively blunted in human subjects with
detectable BAT, suggesting that FGF21
secretion during cold exposure may
require functionally active BAT.
Why would the signal from muscle re-
cruit adipocytes for browning? Irisin
levels are not elevated immediately after
an exercise bout (Bostro¨m et al., 2012),
and now Lee et al. (2014) show that
maximal exercise does not produce as
significant an irisin response as submax-
imal exercise, suggesting that exercise
intensity rather than time determines the
irisin response. This may reflect the
different metabolic milieu that character-
izes these two conditions: glucose and
insulin concentrations are higher after
maximal exercise compared to cold or19, March 4, 2014 ª2014 Elsevier Inc. 353
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Previewssubmaximal exercise, while fatty acid
(FA) concentrations are not affected by
maximal exercise but increase after sub-
maximal exercise (Lee et al., 2014) and
exposure to cold, at least in BAT positive
subjects (Orava et al., 2013). In this
context, shivering may be regarded as
‘‘low-intensity minimal exercise,’’ which
may be important for the irisin response
(Lee et al., 2014). The resulting browning
of subcutaneous WAT may help meet the
need for excess oxidation sites for
released FAs in response to cold, acting
in concert with heat production. Alterna-
tively, submaximal exercise may be
regarded as ‘‘high-intensity shivering,’’
leading to similar responses including
the activation of thermogenesis along
with the oxidation of glucose and FAs in
working muscles.
Overall, the results by Lee et al. (2014)
suggest that irisin and FGF21— induced354 Cell Metabolism 19, March 4, 2014 ª201by submaximal exercise, shivering or
cold—collaborate in promoting the
browning of adipose tissue in order to
meet the increased demand for fat
(and/or glucose) oxidation. In the future,
it will be interesting to explore how
these signals linking muscle and adipose
tissue are regulated in obesity and
whether they could function as a treat-
ment for subjects with nonfunctional
BAT. Moreover, these two players,
though important, are only part of the
puzzle, and new factors will likely add
to our understanding of muscle-adipose
communication and the possibilities for
treatment.
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Axon regeneration capacity often declines with age. One might assume that loss of regeneration is an
obvious consequence of organismal aging. However, in the latest issue ofNeuron, Byrne et al. (2014) demon-
strate that regeneration ability and aging are regulated cell-autonomously within neurons, and can be
decoupled.In animals, the juvenile state is often asso-
ciated with better tissue-repair ability.
Ample evidence suggests that this is
also the case for axon regeneration, an
essential step of neural repair after brain
and spinal cord injury. For example, in
contrast to immature neurons with robust
growth ability, the terminally differentiated
neurons in the adult mammalian central
nervous system possess limited regener-
ative regrowth after injury. Such aging-
associated decline of regenerative growth
has also been observed in themammalian
peripheral nervous system and other
species. These observations suggest apossible connection between axon regen-
eration ability and aging. However, this
issue has never been formally tested due
to the complexity of the system. In an
attempt to address this question, Byrne
and colleagues analyze how aging affects
axon regeneration in C. elegans, and find
that age-dependent decline of axon
regeneration ability is independent of the
life span of the animals. (Byrne et al.,
2014).
C. elegans is a particularly well-adapted
model to address the relationship be-
tween axon regeneration and aging.
Axon regeneration can be easily assessedin vivo by laser axotomy, andC. elegans is
a leading model for aging study. Byrne
and colleagues first observe a 3-fold
decrease in axon regeneration capacity
between young and old adult worms,
corroborating the hypothesis of age-
dependent decline of regeneration. They
then ask whether conditions that delay
aging and increase lifespan could over-
come this effect. They therefore assess
the regeneration capacity of old worms
in three different mutants known to
increase life span (sir-2.1, eat-2, and
daf-2) (Figure 1). They observe that only
the mutation in daf-2, the worm homolog
